Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-11-034017
Filing Date
2011-06-06
Accepted
2011-06-06 06:04:20
Documents
1
Period of Report
2011-06-02

Document Format Files

Seq Description Document Type Size
1 v225019_ex.html 3  
1 v225019_ex.xml 3 2737
  Complete submission text file 0001144204-11-034017.txt   4176
Mailing Address 6330 NANCY RIDGE DRIVE, SUITE 103 SAN DIEGO, CA 92121
Business Address 6330 NANCY RIDGE DRIVE, SUITE 103 SAN DIEGO, CA 92121 (858) 222-8041
APRICUS BIOSCIENCES, INC. (Issuer) CIK: 0001017491 (see all company filings)

EIN.: 870449967 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 11011 NORTH TORREY PINES ROAD LA JOLLA CA 92037
Business Address
Martin Steven Robert (Reporting) CIK: 0001328822 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-22245 | Film No.: 11893873